You are here:Home-Chemical Inhibitors & Agonists-GPCR-Dopamine Receptor-Trazpiroben
Trazpiroben

Chemical Structure : Trazpiroben

CAS No.: 2250200-57-6

Trazpiroben (TAK-906, TAK906)

Catalog No.: PC-72281Not For Human Use, Lab Use Only.

Trazpiroben (TAK-906) is a potent, peripherally selective D2/D3 dopamine receptor antagonist, moderate affinity for D4, and minimal for D1 and D5.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    Trazpiroben (TAK-906) is a potent, peripherally selective D2/D3 dopamine receptor antagonist, moderate affinity for D4, and minimal for D1 and D5.
    Trazpiroben demonstrated the following receptor affinities: high for D2 and D3, moderate for D4, and minimal for D1 and D5, showed moderate affinity for adrenergic α 1B (α 1B) and 5HT)2A receptors and low potential for off-target adverse events (AEs).
    Trazpiroben potently inhibited dopamine-activated D2L receptor activation of cognate G-proteins in human embryonic kidney 293 cell membranes and was a neutral D2L receptor antagonist.
    Trazpiroben dose-dependently increased prolactin release in orally dosed rat (0.1-1 mg/kg).
    Trazpiroben is a potent D2/D3 receptor antagonist designed to avoid the serious potential AEs associated with current gastroparesis.therapies.

    Physicochemical Properties

    M.Wt 633.742
    Formula C35H43N3O8
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid compound with maleic acid (1:1)

    References

    1. Whiting RL, et al. J Pharmacol Exp Ther. 2021 Oct;379(1):85-95.

    2. Whiting RL, et al. Clin Pharmacol Drug Dev. 2021 Aug;10(8):927-939.

    3. Kaur Mukker J, et al. Clin Transl Sci. 2022 Feb 26.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: